• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM Back to Search Results
Catalog Number UNK EMBOSHIELD NAV6
Device Problem Difficult to Advance (2920)
Patient Problems Bradycardia (1751); Pain (1994); Restenosis (4576)
Event Date 03/09/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.Based on the information provided, the difficulty advancing the retrieval catheter was the result of interaction with the deployed stent.The additional treatment was due to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Article, titled: drug-eluting balloon angioplasty for in-stent restenosis following carotid artery stent placement.
 
Event Description
It was reported that the procedure was to treat a left internal carotid artery.A non-abbott guide wire was advanced and placed and a emobshield nav6 embolic protection system (eps) was deployed.A non-abbott balloon catheter was advanced over a hi-torque pilot 200 guide wire.The balloon was inflated to 8 atmospheres (atm); however, was reduced to 6 atm as the patient began to experience local pain and bradycardia.One milligram of atropine was provided intravenously.The balloon was deflated and retracted a little and second inflation was performed at 8 atm.The eps removal was noted to be complicated as there was resistance during advancement of the retrieval catheter through the unspecified deployed stent requiring to advance a non-abbott 6-f guide sheath to remove the filter successfully.There was no clinically significant delay reported.Serial doppler ultrasound was performed at day 1, 1 month, and 6 months post procedure and revealed a decrease in peak systolic velocity and a consistent 20-49% restenosis.Details are listed in the article, titled: drug-eluting balloon angioplasty for in-stent restenosis following carotid artery stent placement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM
Type of Device
EMBOLIC PROTECTION SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11395084
MDR Text Key234185875
Report Number2024168-2021-01562
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141678
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK EMBOSHIELD NAV6
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-